Odense University Hospital: clinical-trial pipeline
Odense University Hospital is the sponsor of 497 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 123 are not yet finished and 7 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Open trials123
Phase 2/3 and 325
Countries14
New in 90 days7
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 371 |
| Phase 4 | 56 |
| Phase 2 | 32 |
| Phase 3 | 18 |
| Phase 2/3 | 7 |
| Phase 1 | 6 |
| Phase 1/2 | 5 |
| Early phase 1 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Completed | 244 |
| Unknown | 110 |
| Recruiting | 77 |
| Not yet recruiting | 24 |
| Active, not recruiting | 22 |
| Terminated | 11 |
| Withdrawn or not authorised | 5 |
| Suspended or halted | 4 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 106 |
| Cardiovascular | 86 |
| Metabolic and endocrine (diabetes, obesity) | 81 |
| Musculoskeletal | 41 |
| Gastroenterology and liver | 40 |
| Immunology and rheumatology | 39 |
| Nephrology and urology | 39 |
| Infectious disease and vaccines | 28 |
| Rare and genetic diseases | 27 |
| Respiratory | 21 |
| Women's health and obstetrics | 21 |
| Dermatology | 17 |
Countries
| Country | Trials |
|---|---|
| Denmark | 464 |
| Norway | 5 |
| Sweden | 5 |
| Germany | 4 |
| United Kingdom | 3 |
| Estonia | 2 |
| Australia | 1 |
| Canada | 1 |
| Finland | 1 |
| Faroe Islands | 1 |
| France | 1 |
| Italy | 1 |
| Russia | 1 |
| United States | 1 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-16 | New trial posted | Effects of a Specialized Diabetes and Heart Clinic and Detection of Unrecognized Heart Fa… |
| 2026-10-16 | New trial posted | Immunoprofiling of the Patient Tumor Microenvironment in BCMA Targeted Therapies |
| 2026-09-29 | New trial posted | Evidence Based Education in Thoracic Ultrasound |
| 2026-09-23 | New trial posted | Optimised Cardiovascular and Renal Protection in Patients With Chronic Kidney Disease and… |
| 2026-08-31 | New trial posted | DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemi… |
| 2026-08-31 | New trial posted | Umbilical Cord Glucose |
| 2026-08-27 | New trial posted | Intraoperative Neurophysiological Monitoring in Brain Tumor Surgery: Prospective Cohort S… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT05062239 | Post-Operative Atrial Fibrillation After Surgical Aortic Valve Replacement and the Influence of Statins | Not applicable | Recruiting | Denmark |
| 2023-503644-13-00 | Topical tacrolimus for the amelioration of breast cancer-related lymphedema: a randomized, double-blind, plac… | Phase 3 | Active, not recruiting | Denmark |
| NCT04095676 | VATS Surgery Compared to Drainage in the Treatment of Pleural Empyema | Not applicable | Recruiting | Denmark |
| NCT06015542 | Self-administration of Subcutaneous Elranatamab in the Patients' Homes. | Phase 2 | Recruiting | Denmark |
| NCT06864130 | A Clinical Study on the Effect of Discontinuing Alendronate in Postmenopausal Women With Osteoporosis After a… | Phase 4 | Recruiting | Denmark |
| 2023-508093-28-00 | Targeting mTOR with everolimus and/or physical training for preventing postmenopausal bone loss and accelerat… | Phase 2 | Recruiting | Denmark |
| NCT06877949 | FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer | Not applicable | Recruiting | Germany, Denmark, Italy |
| 2024-512276-35-00 | Selinexor with alternating bortezomib or lenalidomide plus dexamethasone in transplant ineligible newly diagn… | Phase 2 | Active, not recruiting | Denmark, Estonia, Norway |
| 2022-502770-16-00 | Treatment of Gastroesophageal Reflux Disease in Infants- a Randomized Controlled Trial | Phase 3 | Recruiting | Denmark |
| NCT03280511 | Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients | Phase 2 | Active, not recruiting | Denmark |
| NCT06905587 | Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue | Phase 3 | Recruiting | Denmark |
| NCT06788340 | MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease | Phase 4 | Recruiting | Denmark |
| NCT06295094 | The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients. | Phase 2 | Recruiting | Germany, Denmark, France, Sweden +1 |
| 2024-518773-33-00 | SGL-TX-GFR SGLT2i safety and efficacy on kidney allograft function in non-diabetic kidney transplant recipien… | Phase 4 | Recruiting | Denmark |
| 2024-520372-10-00 | Resistance training and rapamycin to enhance bone formation in postmenopausal women (STRONGBONE) | Phase 2 | Recruiting | Denmark |
| 2025-521941-25-00 | Ipilimumab and nivolumab plus temozolomide and capecitabine for patients with chemo-refractory pMMR, MGMT sil… | Phase 2 | Not yet recruiting | Denmark |
| NCT07733505 | Normethermic Intraperitoneal Chemotherapy - a Novel Concept for Local Treatment of the Elderly and Fragile Wo… | Phase 1 | Recruiting | Denmark |
| NCT07682350 | SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients:… | Phase 2 | Not yet recruiting | Denmark |
| 2024-520251-24-00 | Evidence based empirical antibiotic treatment for urinary tract infections requiring hospitalisation - TRI-AB… | Phase 4 | Recruiting | Denmark |
| NCT07488988 | SCARFREE-001: Verteporfin for Scar Prevention | Phase 2 | Not yet recruiting | Denmark |
| 2025-522956-25-00 | COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffe… | Phase 3 | Not yet recruiting | Denmark |
| NCT07757412 | Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapse… | Phase 2 | Recruiting | Denmark, Estonia, Finland, Norway |
| 2024-519268-41-00 | BEAT Fatigue – Benefit of Elevated Administration of Thiamine for Fatigue in Rheumatoid Arthritis: A randomiz… | Phase 4 | Not yet recruiting | Denmark |
| NCT07795398 | DAN-RELEASE - Reconsidering Long-Term Aspirin in the Elderly Patients With Stable Ischemic Heart Disease | Phase 4 | Recruiting | Denmark |
| NCT07523607 | FAP PET/CT for Staging Patients With Breast Cancer | Phase 2 | Not yet recruiting | Denmark |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "Odense University Hospital clinical trials: 123 open, 25 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/odense-university-hospital/, data as of 2026-10-25.